Skip to main content
UK Licensed Oral Semaglutide

Rybelsus
Oral Weight Loss Treatment

The first oral GLP-1 treatment — semaglutide in a convenient daily tablet. No injections, no refrigeration, no fuss. A prescriber will assess whether this treatment is suitable for you.

Daily Tablet
Proven Weight Loss
Prescriber-Led
No Refrigeration
Rybelsus 1.5mg oral semaglutide tablets — UK licensed packaging
From
£125/month
Genuine UK Licensed
Oral Tablet — No Needles
No Refrigeration Needed
Ongoing Clinical Care
Understanding Your Treatment

What is Rybelsus?

Rybelsus is the brand name for oral semaglutide, a groundbreaking GLP-1 receptor agonist that comes as a convenient daily tablet. It is the world's first and only oral GLP-1 treatment, offering the same proven active ingredient found in Wegovy and Ozempic — but without any injections.

Developed by Novo Nordisk, Rybelsus uses innovative SNAC (Sodium N-[8-(2-hydroxybenzoyl) Amino Caprylate]) absorption technology to protect the semaglutide molecule and enable it to be absorbed through the stomach lining. This breakthrough means you can take clinically proven semaglutide as a simple morning tablet.

By activating GLP-1 receptors, Rybelsus helps regulate appetite, reduce food cravings, and support sustainable weight management. Patients typically experience reduced hunger, smaller portion sizes, and fewer cravings for high-calorie foods — all contributing to meaningful, lasting weight loss.

Important: Off-Label Prescribing

Rybelsus is licensed in the UK by the MHRA for the treatment of Type 2 diabetes. Its use for weight management is considered "off-label" — prescribed at the clinical discretion of a qualified prescriber based on your individual needs. Off-label prescribing is a well-established, legal, and common practice in UK medicine. Your prescriber will fully explain this during your assessment.

The Science

How Rybelsus Works

Two innovative mechanisms working together for effective oral weight management

GLP-1 Receptor Activation

Semaglutide mimics the natural GLP-1 hormone released after eating. By activating GLP-1 receptors in the brain, it reduces appetite, increases feelings of fullness, and helps control food cravings — making it easier to eat less without feeling deprived.

  • Reduces appetite signals in the brain
  • Slows gastric emptying for longer fullness
  • Decreases cravings for high-calorie foods
  • Improves blood sugar regulation

SNAC Absorption Technology

Rybelsus contains SNAC, a patented absorption enhancer that protects the semaglutide molecule from being broken down by stomach acid. SNAC creates a localised pH change that enables semaglutide to pass through the stomach lining into your bloodstream.

  • Protects semaglutide from digestive enzymes
  • Enables oral absorption through stomach lining
  • Must be taken on an empty stomach for efficacy
  • Wait 30 minutes before food or other medications
Clinical Evidence

Expected Results

Based on PIONEER clinical trial data and real-world patient outcomes

5–6%
Average Body Weight Loss
PIONEER Trials
78%
Patients Lost Weight
vs Placebo
12
Weeks to See Results
Typical Onset
1st
Oral GLP-1 Treatment
Worldwide

Your Weight Loss Timeline

Weeks 1–4

Adjustment Phase

Your body adapts to semaglutide. You may notice reduced appetite and fewer cravings. Some mild nausea is normal and usually passes.

Weeks 4–12

Active Weight Loss

Appetite suppression becomes consistent. Most patients begin noticing meaningful weight loss and improved portion control.

Weeks 12–26

Steady Progress

Weight loss continues at a healthy pace. Dose adjustments may be made to optimise your results and manage any side effects.

Weeks 26+

Long-Term Management

Focus shifts to maintaining results. Combined with healthy habits, Rybelsus supports ongoing weight management and metabolic health.

Eligibility

Who Is Rybelsus For?

Our prescribers will assess your suitability during your free consultation

You May Be Eligible If

  • BMI of 30 or above (obese)
  • BMI of 27+ with a weight-related health condition
  • Aged 18 or over
  • Previous weight loss attempts have been unsuccessful
  • You prefer a daily tablet over injections
  • You want a needle-free treatment option
  • Committed to lifestyle changes alongside medication

Rybelsus May Not Be Suitable If

  • You are pregnant, breastfeeding, or planning pregnancy
  • Personal or family history of medullary thyroid carcinoma
  • History of Multiple Endocrine Neoplasia syndrome type 2
  • Severe gastrointestinal disease (e.g. gastroparesis)
  • History of pancreatitis
  • Type 1 diabetes
  • Under 18 years of age
Compare

How Does Rybelsus Compare?

See how Rybelsus stacks up against other leading weight loss treatments

FeatureRybelsusWegovyMounjaroSaxenda
Active IngredientSemaglutideSemaglutideTirzepatideLiraglutide
AdministrationDaily Tablet ✓Weekly InjectionWeekly InjectionDaily Injection
MechanismGLP-1GLP-1GLP-1 + GIPGLP-1
Avg. Weight Loss5–6%15%22.5%5–8%
RefrigerationNot Required ✓RequiredRequiredRequired
Needle-FreeYes ✓NoNoNo
UK Weight Loss LicenceOff-LabelLicensedLicensedLicensed
Starting PriceFrom £125/moLimited SupplyFrom £159/moFrom £99/mo
Pricing

Rybelsus Treatment Plans

Transparent pricing with no hidden fees. All plans include free prescriber assessment and tracked delivery.

Rybelsus 1.5mg UK packaging
Starting Dose
1.5mg
£125/month

Ideal for beginning your Rybelsus journey. Allows your body to adjust to semaglutide with minimal side effects.

  • Free prescriber assessment
  • 28-day supply
  • Tracked Royal Mail delivery
  • Ongoing clinical support
Standard Dose
Rybelsus 4mg UK packaging
Intermediate Dose
4mg
£165/month

The next step up for patients who have tolerated the starting dose well and are ready for increased efficacy.

  • Free prescriber assessment
  • 28-day supply
  • Tracked Royal Mail delivery
  • Ongoing clinical support
Rybelsus 9mg UK packaging
Maintenance Dose
9mg
£175/month

The higher therapeutic dose for maximum appetite suppression and weight loss results.

  • Free prescriber assessment
  • 28-day supply
  • Tracked Royal Mail delivery
  • Ongoing clinical support

Complete Rybelsus Pricing

All prices include medication, prescriber assessment, and delivery

Dose1 Month Supply3 Month Supply
Rybelsus 1.5mg£125£349Save £26
Rybelsus 4mg£165£459Save £36
Rybelsus 9mg£175£489Save £36
Dosing Guide

Dosing Schedule

Your prescriber will guide you through a gradual dose escalation to minimise side effects

1

Starting Dose — 1.5mg

First 4 weeks

Begin with 1.5mg daily to allow your body to adjust to semaglutide. This introductory dose minimises initial side effects while your system adapts.

2

Intermediate Dose — 4mg

Weeks 4–8+

After tolerating the starting dose, your prescriber may increase to 4mg for enhanced appetite suppression and weight loss.

3

Maintenance Dose — 9mg

Ongoing

The 9mg dose delivers maximum therapeutic benefit. Your prescriber will determine the optimal long-term dose based on your response and tolerability.

Daily Dosing Reminder

Take Rybelsus first thing in the morning on an empty stomach with a sip of plain water (up to 120ml). Wait at least 30 minutes before eating, drinking, or taking other oral medications. Consistency is key — take it at the same time every day.

Safety Information

Side Effects & Safety

Like all medications, Rybelsus can cause side effects. Most are mild and temporary.

Common Side Effects

Usually mild and improve as your body adjusts (first 2–4 weeks)

  • Nausea (most common, usually temporary)
  • Diarrhoea or constipation
  • Reduced appetite
  • Stomach discomfort or bloating
  • Headache
  • Mild dizziness

Serious Side Effects

Rare — seek medical attention immediately if you experience

  • Severe abdominal pain (possible pancreatitis)
  • Signs of allergic reaction (swelling, difficulty breathing)
  • Changes in vision
  • Severe or persistent vomiting
  • Signs of low blood sugar (if diabetic)
  • Gallbladder problems (pain under right ribs)
FAQs

Frequently Asked Questions

Everything you need to know about Rybelsus treatment at TLWLC

Ready to Start Your Weight Loss Journey with Rybelsus?

Take the first step today. Our free online assessment takes just 5 minutes, and a qualified prescriber will review your suitability for Rybelsus within 24 hours.

Free Assessment No Needles Required Tracked Delivery Ongoing Support